64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
11 November 2025 · EMJ Respiratory

Authored by Hyfe's R&D team, this review synthesizes work presented at the European Respiratory Society Congress 2025 and argues that objective cough monitoring has crossed a practical threshold, moving from experimental technique to deployable clinical endpoint.
Validated algorithms across smartwatches, chest patches, pendants, and audio recorders now show strong agreement with human annotation (sensitivities of 90 to 97%) across refractory chronic cough, COPD, IPF, ILD, and asthma. The review also covers convergence on a 7-day monitoring standard, device-verified adherence at scale, and early efficacy and tolerability signals from interventional trials using continuous cough endpoints. The authors conclude that cough is transitioning from a background symptom to a quantifiable data stream ready to support precision respiratory care across therapeutic areas.
Bring objective cough data to your study. Schedule a meeting →